Clinical Trials Directory

Trials / Unknown

UnknownNCT03272152

Comprehensive DNA Methylation Profiling in Crohn's Disease

Comprehensive DNA Methylation Profiling of Inflammatory and Non-Inflammatory Mucosa in Crohn's Disease

Status
Unknown
Phase
Study type
Observational
Enrollment
14 (estimated)
Sponsor
Jinling Hospital, China · Academic / Other
Sex
Male
Age
18 Years – 60 Years
Healthy volunteers
Accepted

Summary

Previous studies have indicated that abnormal DNA methylation frequently occurs in the mucosa in Crohn's disease. Comprehensive DNA methylation profiling of the inflamed and non-inflamed ileal mucosa of patients with Crohn's disease was performed. Genome-wide DNA methylation was determined using the Illumina HumanMethylation 850k BeadChip.

Conditions

Interventions

TypeNameDescription
GENETICGenome-wide DNA methylationGenome-wide DNA methylation was determined using the Infinium Human Methylation 850K BeadChip.

Timeline

Start date
2017-01-01
Primary completion
2017-09-30
Completion
2017-09-30
First posted
2017-09-05
Last updated
2017-09-05

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT03272152. Inclusion in this directory is not an endorsement.